Literature DB >> 12788025

C to A single nucleotide polymorphism in intron 18 of the human MST1R (RON) gene that maps at 3p21.3.

Debora Angeloni1, Fuh-Mei Duh, Michele Moody, Michael Dean, Eugene R Zabarovsky, Vera Sentchenko, Eleonora Braga, Michael I Lerman.   

Abstract

The MST1R (RON) gene, that maps at 3p21.3, encodes a protein tyrosine kinase receptor comprised of an extra-cellular domain that contains the ligand binding pocket and an intracellular region where the kinase domain is located. It controls cell survival and motility programs related to invasive growth. With the single strand conformation polymorphism (SSCP) method, a C to A nucleotide polymorphism (SNP) was found in intron 18 of the gene. The SNP has a frequency of 0.28 among African-American, 0.25 among Caucasian CEPH and 0.09 among Asian healthy individuals. During these studies, an alternatively spliced cDNA of MST1R, lacking exon 19, was also found that may result from this change.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788025     DOI: 10.1016/s0890-8508(02)00115-9

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  3 in total

1.  A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance.

Authors:  Jacqueline Olender; Bi-Dar Wang; Travers Ching; Lana X Garmire; Kaitlin Garofano; Youngmi Ji; Tessa Knox; Patricia Latham; Kenneth Nguyen; Johng Rhim; Norman H Lee
Journal:  Mol Cancer Res       Date:  2019-07-02       Impact factor: 5.852

2.  Variant RONΔ160 of the RON receptor tyrosine kinase promotes the growth and invasion in vitro and in vivo in gastric cancer cell lines.

Authors:  Dong-Hui Zhou; Chao Li; Li-Na Yang
Journal:  Cancer Cell Int       Date:  2015-02-04       Impact factor: 5.722

3.  Identification of common genetic variation that modulates alternative splicing.

Authors:  Jeremy Hull; Susana Campino; Kate Rowlands; Man-Suen Chan; Richard R Copley; Martin S Taylor; Kirk Rockett; Gareth Elvidge; Brendan Keating; Julian Knight; Dominic Kwiatkowski
Journal:  PLoS Genet       Date:  2007-06       Impact factor: 5.917

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.